Background Hyperglycemia has been reported in some patients after
curative insulinoma resection but no systematic investigation of glucose
metabolism has been shown in a larger cohort of these patients. Therefore,
it is still unknown, whether long lasting hyperinsulinism in insulinoma
patients induces insulin resistance, which may jeopardize the postoperative
health status of these patients.
Methods Early postoperative fasting serum glucose levels were
measured in all insulinoma patients after curative tumor resection during
the first 48 h, being operated between 2011 and 2018,
retrospectively.
Results Of 77 (100%) patients with benign, spontaneous
occuring insulinoma 51 (66.2%) patients were operated on by tumor
enucleation. In 15 (19.5%) patients a left pancreatic resection was
performed and in 11 (14.3%) patients the pancreatic head or the
middle console of pancreatic corpus were excised. In 32 (41.6%)
cases the highest fasting postoperative glucose levels were measured between
140–200 mg/dl. In 16 (20.8%) patients the
glucose serum levels reached values above 200 mg/dl and in 4
(5.2%) patients short term substitution with insulin was indicated.
Only one (1.3%) of these patients developed diabetes mellitus with
the need of ongoing insulin treatment. Major postoperative complications
were registered in 31 of all 77 patients (40.3%) and in 9 of 16
patients (56.3%) with postoperative glucose levels above
200 mg/dl. This difference was not statistically
significant.
Conclusions Early postoperative (first 48 h) fasting serum
glucose levels in insulinoma patients showed significant hyperglycemia above
200 mg/dl in only few patients (20.8%) and chronic
postoperative Diabetes mellitus developed in only one of 77 patients
(<2%). Therefore, recovery of glucose metabolism after
insulinoma resection is fast and medical intervention is not mandatory in
most of these patients.